enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Alnylam Pharmaceuticals - Wikipedia

   en.wikipedia.org/wiki/Alnylam_Pharmaceuticals

   Alnylam still does not earn money, but writes losses. The losses ("GAAP Operating Loss") from Alnylam were around $650 million in the late 2020. Alnylam expects to achieve net profits financially in 2022 or 2023. [40] In July 2023, Roche partnered with Alnylam Pharmaceuticals in a deal worth $2.8 billion for the development of a hypertension ...

3. Alnylam's Biggest Opportunities - AOL

   www.aol.com/news/2013-10-01-alnylams-biggest...

   Shares of Alnylam Pharmaceuticals (NASDAQ: ALNY), a biotech company developing a new class of medications based on RNAi technology, have soared 250% since the start of 2013. Why are investors so ...

4. Amy Schulman - Wikipedia

   en.wikipedia.org/wiki/Amy_Schulman

   Amy Weinfeld Schulman is an American healthcare biotech venture capitalist, trained as a lawyer, who serves as a managing partner at Polaris Partners. [1] [2] [3] She focuses on investing in healthcare companies and early-stage biotech start-ups.

5. Yvonne Greenstreet - Wikipedia

   en.wikipedia.org/wiki/Yvonne_Greenstreet

   Wanting to "impact more than the hundred or so patients I would see in a year", Greenstreet switched career, gaining a master's degree at the INSEAD Business School in France. In 1992, she joined the pharmaceutical firm Glaxo, which later became GlaxoSmithKline (GSK). [ 1 ]

6. Analysts Put Alnylam On Upside Catalyst Watch Ahead Of ... - AOL

   www.aol.com/news/analysts-put-alnylam-upside...

   RBC Capital Markets raised the price target on Alnylam Pharmaceuticals Inc (NASDAQ: ALNY) from $225 to $250. The analyst says that the company is confident that the recent APOLLO-B validates the ...

7. Is a Surprise Coming for Alnylam (ALNY) This Earnings Season?

   www.aol.com/news/surprise-coming-alnylam-alny...

   For premium support please call: 800-290-4726 more ways to reach us